Titre : Récepteurs CCR5

Récepteurs CCR5 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Methicillin-Resistant Staphylococcus aureus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Récepteurs CCR5 : Questions médicales les plus fréquentes", "headline": "Récepteurs CCR5 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Récepteurs CCR5 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-05", "dateModified": "2025-03-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Récepteurs CCR5" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Récepteur VIH", "url": "https://questionsmedicales.fr/mesh/D015728", "about": { "@type": "MedicalCondition", "name": "Récepteur VIH", "code": { "@type": "MedicalCode", "code": "D015728", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.830.700" } } }, "about": { "@type": "MedicalCondition", "name": "Récepteurs CCR5", "alternateName": "Receptors, CCR5", "code": { "@type": "MedicalCode", "code": "D019713", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Richard G Pestell", "url": "https://questionsmedicales.fr/author/Richard%20G%20Pestell", "affiliation": { "@type": "Organization", "name": "Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, PA, United States; Wistar Institute, Philadelphia, PA, United States; Xavier University School of Medicine, Woodbury, NY, United States. Electronic address: richard.pestell@bblumberg.org." } }, { "@type": "Person", "name": "Xuanmao Jiao", "url": "https://questionsmedicales.fr/author/Xuanmao%20Jiao", "affiliation": { "@type": "Organization", "name": "Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, PA, United States." } }, { "@type": "Person", "name": "Yang Shen", "url": "https://questionsmedicales.fr/author/Yang%20Shen", "affiliation": { "@type": "Organization", "name": "Neurobiology, Psychiatry and Psychology Departments & Integrative Center for Learning and Memory, UCLA, Los Angeles, CA." } }, { "@type": "Person", "name": "Miou Zhou", "url": "https://questionsmedicales.fr/author/Miou%20Zhou", "affiliation": { "@type": "Organization", "name": "College of Dental Medicine, Western University of Health Sciences, Pomona, CA. Electronic address: mzhou@westernu.edu." } }, { "@type": "Person", "name": "Raquel Blanco", "url": "https://questionsmedicales.fr/author/Raquel%20Blanco", "affiliation": { "@type": "Organization", "name": "Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB/CSIC), Madrid, Spain." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Methicillin-resistant Staphylococcus aureus-associated orbital cellulitis: a case series.", "datePublished": "2023-04-07", "url": "https://questionsmedicales.fr/article/37029211", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10792-023-02698-y" } }, { "@type": "ScholarlyArticle", "name": "Mptx2 defends against peritoneal infection by methicillin-resistant staphylococcus aureus.", "datePublished": "2022-05-21", "url": "https://questionsmedicales.fr/article/35609377", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.intimp.2022.108856" } }, { "@type": "ScholarlyArticle", "name": "Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis.", "datePublished": "2024-10-10", "url": "https://questionsmedicales.fr/article/39390563", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13052-024-01780-0" } }, { "@type": "ScholarlyArticle", "name": "[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children].", "datePublished": "2024-01-22", "url": "https://questionsmedicales.fr/article/38245868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.37201/req/113.2023" } }, { "@type": "ScholarlyArticle", "name": "Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36371648", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/phar.2741" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Récepteurs de surface cellulaire", "item": "https://questionsmedicales.fr/mesh/D011956" }, { "@type": "ListItem", "position": 6, "name": "Récepteurs viraux", "item": "https://questionsmedicales.fr/mesh/D011991" }, { "@type": "ListItem", "position": 7, "name": "Récepteur VIH", "item": "https://questionsmedicales.fr/mesh/D015728" }, { "@type": "ListItem", "position": 8, "name": "Récepteurs CCR5", "item": "https://questionsmedicales.fr/mesh/D019713" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Récepteurs CCR5 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Récepteurs CCR5", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Récepteurs CCR5", "description": "Comment diagnostiquer une infection par le VIH ?\nQuels tests évaluent les récepteurs CCR5 ?\nQuels symptômes indiquent une infection par le VIH ?\nComment évaluer la résistance au VIH ?\nQuel rôle joue CCR5 dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D019713?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Récepteurs CCR5", "description": "Quels sont les symptômes d'une infection par le VIH ?\nComment les récepteurs CCR5 affectent-ils l'immunité ?\nQuels symptômes sont liés à l'inhibition de CCR5 ?\nLes symptômes varient-ils selon le génotype de CCR5 ?\nQuels signes indiquent une progression de l'infection ?", "url": "https://questionsmedicales.fr/mesh/D019713?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Récepteurs CCR5", "description": "Comment prévenir l'infection par le VIH ?\nQuel rôle joue l'éducation dans la prévention ?\nLes vaccins contre le VIH existent-ils ?\nComment la PrEP aide-t-elle à prévenir le VIH ?\nLes tests réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D019713?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Récepteurs CCR5", "description": "Quels traitements ciblent les récepteurs CCR5 ?\nComment les traitements antirétroviraux agissent-ils ?\nQuels sont les effets secondaires des inhibiteurs de CCR5 ?\nLes traitements sont-ils efficaces pour tous les patients ?\nComment surveiller l'efficacité du traitement ?", "url": "https://questionsmedicales.fr/mesh/D019713?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Récepteurs CCR5", "description": "Quelles complications peuvent survenir avec le VIH ?\nComment les récepteurs CCR5 influencent-ils les complications ?\nQuels sont les risques de résistance aux traitements ?\nLes complications sont-elles réversibles ?\nComment prévenir les complications liées au VIH ?", "url": "https://questionsmedicales.fr/mesh/D019713?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Récepteurs CCR5", "description": "Quels sont les principaux facteurs de risque du VIH ?\nLe génotype de CCR5 influence-t-il le risque d'infection ?\nComment l'usage de drogues affecte-t-il le risque ?\nLes antécédents familiaux influencent-ils le risque ?\nQuel rôle joue l'âge dans le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D019713?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par le VIH ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test sanguin détectant les anticorps ou l'ARN du VIH est utilisé." } }, { "@type": "Question", "name": "Quels tests évaluent les récepteurs CCR5 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de surface cellulaire peuvent être effectués." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection par le VIH ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes incluent fièvre, fatigue, éruptions cutanées et ganglions enflés." } }, { "@type": "Question", "name": "Comment évaluer la résistance au VIH ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de résistance virale mesurent l'efficacité des traitements antirétroviraux." } }, { "@type": "Question", "name": "Quel rôle joue CCR5 dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "CCR5 est un co-récepteur essentiel pour l'entrée du VIH dans les cellules." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection par le VIH ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, fatigue, maux de tête et éruptions cutanées." } }, { "@type": "Question", "name": "Comment les récepteurs CCR5 affectent-ils l'immunité ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils modulent la réponse immunitaire, influençant l'inflammation et l'infection." } }, { "@type": "Question", "name": "Quels symptômes sont liés à l'inhibition de CCR5 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une inhibition peut réduire l'inflammation, mais causer des effets secondaires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le génotype de CCR5 ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines variations génétiques peuvent influencer la gravité des symptômes." } }, { "@type": "Question", "name": "Quels signes indiquent une progression de l'infection ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Perte de poids, infections opportunistes et fatigue chronique sont des signes." } }, { "@type": "Question", "name": "Comment prévenir l'infection par le VIH ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des préservatifs, se faire dépister et prendre des médicaments préventifs." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation sur le VIH et les comportements à risque est cruciale pour la prévention." } }, { "@type": "Question", "name": "Les vaccins contre le VIH existent-ils ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, aucun vaccin efficace n'est disponible, mais des recherches sont en cours." } }, { "@type": "Question", "name": "Comment la PrEP aide-t-elle à prévenir le VIH ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "La PrEP réduit le risque d'infection en bloquant l'entrée du VIH dans les cellules." } }, { "@type": "Question", "name": "Les tests réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage régulier aide à détecter l'infection précocement et à prévenir sa propagation." } }, { "@type": "Question", "name": "Quels traitements ciblent les récepteurs CCR5 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les inhibiteurs de CCR5, comme le maraviroc, sont utilisés dans le VIH." } }, { "@type": "Question", "name": "Comment les traitements antirétroviraux agissent-ils ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils bloquent la réplication virale, empêchant le VIH d'infecter de nouvelles cellules." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des inhibiteurs de CCR5 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent causer des nausées, des éruptions cutanées et des infections respiratoires." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces pour tous les patients ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'efficacité dépend du génotype du VIH et de la réponse individuelle." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des tests réguliers de charge virale et de CD4 sont nécessaires pour évaluer la réponse." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le VIH ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent les infections opportunistes et les cancers associés au VIH." } }, { "@type": "Question", "name": "Comment les récepteurs CCR5 influencent-ils les complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent moduler la réponse immunitaire, augmentant le risque de complications." } }, { "@type": "Question", "name": "Quels sont les risques de résistance aux traitements ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise adhésion au traitement peut entraîner une résistance virale et des complications." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment prévenir les complications liées au VIH ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement antirétroviral efficace et un suivi médical régulier sont essentiels." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du VIH ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les rapports sexuels non protégés, le partage de seringues et l'absence de dépistage." } }, { "@type": "Question", "name": "Le génotype de CCR5 influence-t-il le risque d'infection ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines variations génétiques peuvent conférer une protection contre le VIH." } }, { "@type": "Question", "name": "Comment l'usage de drogues affecte-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'usage de drogues injectables augmente le risque de transmission du VIH par le partage de seringues." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies immunitaires peuvent augmenter le risque." } }, { "@type": "Question", "name": "Quel rôle joue l'âge dans le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les jeunes adultes sont souvent plus à risque en raison de comportements à risque plus fréquents." } } ] } ] }

Sources (10000 au total)

Methicillin-resistant Staphylococcus aureus-associated orbital cellulitis: a case series.

In recent years, methicillin-resistant Staphylococcus aureus (MRSA) orbital cellulitis (OC) has drawn increasing clinical and public health concern. We present a case series of MRSA OC encountered at ... A multi-centre retrospective case series investigating MRSA OC in Australia from 2013 to 2022. Patients of all ages were included.... Nine cases of culture-positive non-multi-resistant MRSA (nmMRSA) OC were identified at four tertiary institutions across Australia (7 male, 2 female). Mean age was 17.1 ± 16.7 years (range 13-days to ... NMMRSA OC can follow an aggressive clinical course causing severe orbital and intracranial complications across a wide demographic. However, early recognition, initiation of targeted antibiotics and s...

Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis.

This study aims to identify risk factors associated with Methicillin-resistant Staphylococcus aureus (MRSA) infection in children diagnosed with acute osteomyelitis (AO) and to elucidate the laborator... We conducted a retrospective analysis involving 123 children with acute osteomyelitis treated at our hospital. Upon admission, we measured white blood cell (WBC) counts, C-reactive protein (CRP) level... The MRSA group had a significantly higher average age compared to the non-MRSA group (P < 0.05). Notably, the incidence of suppurative arthritis was significantly lower in the MRSA group (P < 0.05). A... In children newly admitted with acute osteomyelitis, a CRP level exceeding 73.23 µg/mL may indicate a high likelihood of MRSA infection. For children with AO who have been hospitalized for three days ...

[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children].

The objectives of this work were to know the prevalence of methicillin-resistant S. aureus (MRSA) infections in the paediatric population of our health department, to describe the risk factors for inf... A retrospective, descriptive and analytical study of infections produced by MRSA versus those produced by MSSA was carried out during the years 2014 to 2018. Risk factors for MRSA infection were studi... 162 patients with S. aureus infections were identified. Of these, 25 (15.4%) were MRSA. The highest percentages of MRSA infection occurred among children who required hospital admission (23.4%). In th... Our results suggest the need to review empirical local treatment regimen using drugs active against MRSA in infections of probable staphylococcal origin admitted to the hospital, especially if they ha...

Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.

The preferred antibiotic salvage regimen for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is unclear. We sought to evaluate the effectiveness and safety of vancomycin plus... Single-center, retrospective cohort study between January 1, 2016, and December 31, 2021.... State University of New York Upstate University Hospital, a 748-bed tertiary care, academic medical center in Syracuse, NY.... Adult patients were included if they had blood cultures positive for MRSA ≥72 h, received vancomycin monotherapy initially, and received vancomycin plus ceftaroline for ≥24 h. Patients were excluded i... Patients were medically complex with a median Pitt bacteremia score of 3, 63.3% (19/30) were admitted to the intensive care unit, and 66.7% (20/30) had infective endocarditis. Vancomycin-associated ac... Vancomycin plus ceftaroline may represent an effective and well-tolerated salvage regimen option for persistent MRSAB....

Rate of methicillin-resistant Staphylococcus aureus in pediatric emergency departments in Spain.

Staphylococcus aureus is a common germ in bacterial infections in children. The rate of methicillin-resistant S. aureus (MRSA) is increasing lately.... The main aim is to know the rate of positive cultures to MRSA in Spanish pediatric emergency departments. The secondary aims are to analyse the risk factors for MRSA isolation (patient origin, history... Retrospective multicenter study (07/01/2017-06/30/2018) with review of patient histories with isolation of S. aureus in samples of any origin obtained in 8 pediatric emergency departments of the Infec... During this period, S. aureus was detected in 403 patients (average age 75.8 ± 59.2 months; 54.8% male): 28.8% hospital-related infections (HRI) and 71.2% community-related infections (CRI). Overall, ... The overall MRSA rate was one in 6 staphylococcal infections. Higher MRSA rates were detected in samples of suppurating skin injuries and in foreign children or in children with a history of previous ...

Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus.

We aimed to determine the synergistic effects of ceftaroline (CPT) in combination with daptomycin (DAP), vancomycin (VAN), or linezolid (LNZ) against various methicillin-resistant Staphylococcus aureu... MRSA strains randomly selected from 2014 to 2018 were studied. Checkerboard titration and in vitro time-kill analyses were used to determine the synergistic activities of the antibiotic combinations.... A total of 10 genetically distinct MRSA strains were included in this study. The checkerboard titration analysis revealed that the CPT-DAP, CPT-VAN, and CPT-LNZ combinations had a synergistic effect a... The CPT-DAP combination showed better synergistic activity than the CPT-VAN and CPT-LNZ combinations against the enrolled MRSA strains. DAP, rather than VAN or LNZ, might be a better choice for CPT co...

Using Methicillin-Resistant Staphylococcus aureus Nasal Screens to Rule Out Methicillin-Resistant S aureus Pneumonia in Surgical Intensive Care Units.

The methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) has a high negative predictive value (NPV). We aimed to understand if there was a difference in the NPV of the MR... We performed a single-center, retrospective cohort study of adults with a positive respiratory culture and MRSA nasal PCR admitted to a surgical ICU from 2016 to 2019. Patients were stratified by surg... We analyzed 61 patients: 42.6% (n = 26) ACS-ICU and 57.4% (n = 35) CVICU. There were no differences in age, comorbidities, prior MRSA infection, recent antibiotic use, immunocompromised status, or ren... The MRSA nasal PCR screen has a high NPV for ruling out MRSA pneumonia in critically ill surgical patients. However, patients in the CVICU and patients hospitalized ≥5 d had a longer time to de-escala...

Molecular epidemiology, virulence and antimicrobial resistance of Bulgarian methicillin resistant Staphylococcus aureus isolates.

Severe infections of virulent methicillin-resistant Staphylococcus aureus (MRSA) are a serious health problem. The present study aimed to investigate clonal spread, virulence and antimicrobial resista... Molecular identification and mecA gene detection were performed with PCR. Clonal relatedness was evaluated by RAPD PCR and MLST. MRSA epidemiology, virulence and resistance patterns were investigated ... All 27 isolates were identified as S. aureus and were mecA positive, and all were susceptible to linezolid, tigecycline and vancomycin. The toxin genes hlg (in 92.6% of isolates), seb (77.8%), sei (77... To the best of our knowledge, this study is the first describing the clonal spreading of Bulgarian MRSA and the association with their virulence and resistance determinants. Monitoring of MRSA epidemi...

Comparing Rates of Postoperative Meningitis After Endoscopic Endonasal Procedures Based on Methicillin-Resistant Staphylococcus aureus/Methicillin-Sensitive Staphylococcus aureus Colonization and Antibiotic Prophylaxis.

Endoscopic endonasal approach (EEA) procedures are inherently contaminated due to direct access through the nasopharyngeal mucosa. The reported rate of postoperative meningitis in EEA procedures is 0.... All adult patients who underwent EEA resection at our institution from 2013 to 2021 were retrospectively reviewed. Patients with preoperative cerebrospinal fluid infections were excluded. Data includi... Of 483 patients identified (mean age, 51 years; range, 18-90 years; 274 [56.7%] female), 80 (16.6%) had a positive preoperative methicillin-resistant Staphylococcus aureus (MRSA)/methicillin-sensitive... Postoperative rates of meningitis after EEA surgery were not significantly changed based on MRSA/MSSA colonization status of the patient or preoperative decolonization. The utility of preoperative tes...